Skip to main content
. 2023 Sep 29;32:66–97. doi: 10.1016/j.bioactmat.2023.09.015

Fig. 8.

Fig. 8

Gene-interference ferroptosis therapy (GIFT). (a) A schematic diagram of CRISPR/cas13a- and miRNA-based GIFT. (b) Stability of the DMSA-coated Fe3O4 nanoparticles over 90 days. (c–d) The in vivo antitumor effect of GIFT in (c) WEHI-3-xenografted mice and (d) CT-26-xenografted mice. Data are presented as the mean ± standard deviation (n = 10 mice). Reproduced with permission [151]. Copyright 2021, Springer Nature.